Varian Medical Systems, Inc. and Subsidiaries

CourtUnited States Tax Court
DecidedAugust 26, 2024
Docket8435-23
StatusPublished

This text of Varian Medical Systems, Inc. and Subsidiaries (Varian Medical Systems, Inc. and Subsidiaries) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Varian Medical Systems, Inc. and Subsidiaries, (tax 2024).

Opinion

United States Tax Court

163 T.C. No. 4

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES, Petitioner

v.

COMMISSIONER OF INTERNAL REVENUE, Respondent

—————

Docket No. 8435-23. Filed August 26, 2024.

I.R.C. § 245A, which was enacted by the Tax Cuts and Jobs Act (TCJA), Pub. L. No. 115-97, § 14101, 131 Stat. 2054, 2189 (2017), provides a deduction (DRD) for certain dividends received by a U.S. corporation from certain foreign corporations. Given its formulation, the DRD had the potential to interact with existing I.R.C. § 78. As in effect before the TCJA, I.R.C. § 78 provided that, for taxpayers who claimed foreign tax credits, a specified amount “shall be treated for purposes of this title (other than [I.R.C. §] 245) as a dividend received by such domestic corporation from the foreign corporation.” TCJA amended I.R.C. § 78 to provide that amounts treated as dividends under I.R.C. § 78 do not qualify for the DRD under I.R.C. § 245A. But in certain circumstances, TCJA’s amendments to I.R.C. § 78 did not take effect until a tax year starting after I.R.C. § 245A took effect.

Relying on this effective date mismatch, for fiscal year 2018, P claimed the DRD for an amount it treated as a dividend under I.R.C. § 78. In its Motion for Partial Summary Judgment, P argues that it is entitled to the DRD for this amount plus an additional amount alleged in its Petition. R disagrees in his own Cross-Motion for Partial Summary Judgment. Additionally, R argues in the alternative that, if we find P is entitled to the DRD for

Served 08/26/24 2

amounts treated as dividends under I.R.C. § 78, then I.R.C. § 245A(d)(1) limits the foreign tax credits to which P would otherwise be entitled.

Held: P is entitled under I.R.C. § 245A to a deduction for amounts properly treated as dividends under I.R.C. § 78 for its 2018 tax year.

Held, further, Treas. Reg. § 1.78-1 does not alter this conclusion because it cannot contravene the clear statutory text.

Held, further, I.R.C. § 245A(d)(1) disallows foreign tax credits to the extent they are attributable to amounts P properly treats as dividends under I.R.C. § 78 and deducts under I.R.C. § 245A.

Held, further, P’s Motion will be granted in part, and R’s Motion will be granted in part.

Jean A. Pawlow, Andrew C. Strelka, Eric J. Konopka, and Alexandra B. Clionsky Kelly, for petitioner.

Andrew M. Tiktin, David J. Berke, Meenu Kapai, Usha Ravi, and H. Clifton Bonney, Jr., for respondent.

OPINION

TORO, Judge: We must address in this deficiency case two questions of first impression: (1) how do two effective date provisions enacted by the Tax Cuts and Jobs Act (TCJA), Pub. L. No. 115-97, 131 Stat. 2054 (2017), and an existing provision of the Internal Revenue Code (section 78) 1 interact and (2) how does a new Code provision

1 Unless otherwise indicated, statutory references are to the Internal Revenue

Code, Title 26 U.S.C. (I.R.C. or Code), in effect at all relevant times, regulation references are to the Code of Federal Regulations, Title 26 (Treas. Reg.), in effect at all relevant times, and Rule references are to the Tax Court Rules of Practice and Procedure. 3

enacted by the TCJA (section 245A) actually apply? We answer both questions by following the plain text of the relevant provisions.

Congress enacted the TCJA in 2017. Among other things, the TCJA added to the Code new section 245A, which allows a domestic corporation a deduction for certain dividends received from foreign subsidiaries. Section 245A applies to “distributions made after . . . December 31, 2017.” TCJA § 14101(f), 131 Stat. at 2192.

Because the deduction under section 245A applies to dividends received by a domestic corporation from a foreign corporation, it had the potential to interact with existing section 78. As in effect before the adoption of the TCJA, that section provided that, for taxpayers who claimed foreign tax credits, a specified amount “shall be treated for purposes of this title (other than section 245) as a dividend received by such domestic corporation from the foreign corporation.”

Recognizing that section 245A might otherwise allow a taxpayer who claims foreign tax credits to deduct a dividend that section 78 would have deemed the taxpayer to receive, the TCJA amended section 78 to preclude that result. But, instead of using the same effective date that it applied to section 245A, the TCJA amended section 78 for “taxable years of foreign corporations beginning after December 31, 2017, and . . . taxable years of United States shareholders in which or with which such taxable years of foreign corporations end.” TCJA § 14301(d), 131 Stat. at 2225.

For some taxpayers—including those with foreign subsidiaries with fiscal years (that is, foreign subsidiaries whose taxable years do not run from January 1 to December 31 of each year)—this effective date mismatch created a window during which section 245A was in effect, but the amendments to section 78 were not. The question before us is whether, during that window, section 245A provided one such taxpayer, Varian Medical Systems, Inc. (Varian), a deduction for a dividend that it was deemed to receive under section 78.

Seeking partial summary judgment, the Commissioner argues that, despite the disparate effective dates, Varian cannot claim a deduction for its section 78 dividend because section 245A permits a deduction only for dividends that are actually distributed (or treated as distributed) from earnings, and, in the Commissioner’s view, section 78 dividends do not satisfy this requirement. Alternatively, the 4

Commissioner argues that Treasury Regulation § 1.78-1, as amended June 21, 2019, disallows the deduction.

Varian disagrees, arguing that the operative text of section 245A permits the deduction and that no other provision prohibits it. Varian also argues that Treasury Regulation § 1.78-1 is invalid because it purports to apply amended section 78 to a period starting before the effective date provided in the TCJA. It therefore seeks partial summary judgment in its favor.

Because a plain reading of the statutory text authorizes the deduction under section 245A, we will grant Varian’s Motion for Partial Summary Judgment. Relatedly, we will deny the Commissioner’s Cross- Motion for Partial Summary Judgment insofar as he asks us to conclude that Varian cannot claim a deduction under section 245A for any section 78 dividend.

The Commissioner also argues that, if Varian is entitled to the deduction, section 245A(d)(1) limits the amount of foreign tax credits Varian may claim. We agree with the Commissioner on this point and therefore will grant his Motion in part.

Background

The following facts are derived from the parties’ pleadings and Motion papers. They are stated solely for the purpose of ruling on the Motions before us and not as findings of fact in this case. See Rowen v. Commissioner, 156 T.C. 101, 103 (2021) (reviewed).

Originally founded in 1948, Varian is the parent company of a consolidated group of medical device and software manufacturers. Its principal place of business is in Palo Alto, California.

Varian operates through corporations in many different countries, at least some of which are controlled foreign corporations (CFCs) as that term is defined in section 957(a). Varian and its CFCs are fiscal year taxpayers, meaning their taxable years do not end on December 31. See I.R.C. § 441(a), (d), (e). As relevant for this case, the fiscal year of Varian and its CFCs started on September 30, 2017, and ended on September 28, 2018 (2018 Year).

Varian filed a consolidated federal income tax return for the 2018 Year. On the return, Varian elected to claim foreign tax credits for foreign taxes that it was deemed to pay under section 960 and was 5

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Marbury v. Madison
5 U.S. 137 (Supreme Court, 1803)
Cook v. Tait
265 U.S. 47 (Supreme Court, 1924)
Iselin v. United States
270 U.S. 245 (Supreme Court, 1926)
Crooks v. Harrelson
282 U.S. 55 (Supreme Court, 1930)
Burnet v. Chicago Portrait Co.
285 U.S. 1 (Supreme Court, 1932)
Koshland v. Helvering
298 U.S. 441 (Supreme Court, 1936)
American Chicle Co. v. United States
316 U.S. 450 (Supreme Court, 1942)
Skidmore v. Swift & Co.
323 U.S. 134 (Supreme Court, 1944)
United States v. Menasche
348 U.S. 528 (Supreme Court, 1955)
Commissioner v. Bilder
369 U.S. 499 (Supreme Court, 1962)
Commissioner v. Idaho Power Co.
418 U.S. 1 (Supreme Court, 1974)
Mobil Oil Corp. v. Higginbotham
436 U.S. 618 (Supreme Court, 1978)
Russello v. United States
464 U.S. 16 (Supreme Court, 1983)
United States v. Locke
471 U.S. 84 (Supreme Court, 1985)
United States v. Ron Pair Enterprises, Inc.
489 U.S. 235 (Supreme Court, 1989)
United States v. Goodyear Tire & Rubber Co.
493 U.S. 132 (Supreme Court, 1990)
Connecticut National Bank v. Germain
503 U.S. 249 (Supreme Court, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
Varian Medical Systems, Inc. and Subsidiaries, Counsel Stack Legal Research, https://law.counselstack.com/opinion/varian-medical-systems-inc-and-subsidiaries-tax-2024.